Journal article
Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances
YC Raymond, S Fernando, M Menezes, S Meagher, BW Mol, A McLennan, F Scott, K Mizia, K Carey, G Fleming, DL Rolnik
Prenatal Diagnosis | Published : 2022
DOI: 10.1002/pd.6233
Abstract
Objective: To assess the outcomes of pregnancies at high-risk for rare autosomal trisomies (RATs) and segmental imbalances (SIs) on cell-free DNA (cfDNA) screening. Method: A retrospective study of women who underwent cfDNA screening between September 2019 and July 2021 at three ultrasound services in Australia. Positive predictive values (PPVs) were calculated using fetal chromosomal analysis. Results: Among 23,857 women screened, there were 93 high-risk results for RATs (0.39%) and 82 for SIs (0.34%). The PPVs were 3.8% (3/78, 95% CI 0.8%–10.8%) for RATs and 19.1% (13/68, 95% CI 10.6%–30.5%) for SIs. If fetuses with structural anomalies were also counted as true-positive cases, the PPV for..
View full abstractGrants
Awarded by Merck